Guangzhou Baiyunshan Pharma_ Risk Reward Update
Bazaarvoice·2024-12-26 03:07
Morgan Stanley Research 9 Keymed Biosciences Inc. (2162.HK) O (08/10/2021) HK$31.85 M Update | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------|-------| | Everest Medicines Ltd (1952.HK) E (03/15/2024) HK$46.80 \nHUTCHMED (China) Ltd (0013.HK) E (04 ...